{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T02:15:08Z","timestamp":1788228908560,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["72274045"],"award-info":[{"award-number":["72274045"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["71974048"],"award-info":[{"award-number":["71974048"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.isci.2026.116334","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T09:00:34Z","timestamp":1782118834000},"page":"116334","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Assessing the health utility values of patients with six common cancers in China using the QLU-C10D: A cross-sectional survey"],"prefix":"10.1016","volume":"29","author":[{"given":"Jiaxuan","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lemin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haofei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Sakhno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjuan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6107-5305","authenticated-orcid":false,"given":"Weidong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2026.116334_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clinicians"},{"key":"10.1016\/j.isci.2026.116334_bib2","first-page":"47","article-title":"Cancer incidence and mortality in China, 2022","volume":"4","author":"Han","year":"2024","journal-title":"J. Natl. Cancer Cent."},{"key":"10.1016\/j.isci.2026.116334_bib3","doi-asserted-by":"crossref","first-page":"e943","DOI":"10.1016\/S2468-2667(23)00211-6","article-title":"National and subnational trends in cancer burden in China, 2005-20: an analysis of national mortality surveillance data","volume":"8","author":"Qi","year":"2023","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.isci.2026.116334_bib4","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/jamaoncol.2022.7826","article-title":"Estimates and Projections of the Global Economic Cost of 29 Cancers in 204 Countries and Territories From 2020 to 2050","volume":"9","author":"Chen","year":"2023","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.isci.2026.116334_bib5","first-page":"859","article-title":"Cost-utility analysis","volume":"307","author":"Robinson","year":"1993","journal-title":"Economic Evaluation and Health Care"},{"key":"10.1016\/j.isci.2026.116334_bib6","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","article-title":"EuroQol - a new facility for the measurement of health-related quality of life","volume":"16","author":"Group","year":"1990","journal-title":"Health Policy"},{"key":"10.1016\/j.isci.2026.116334_bib7","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s40273-020-00997-1","article-title":"Valuation of SF-6Dv2 Health States in China Using Time Trade-off and Discrete-Choice Experiment with a Duration Dimension","volume":"39","author":"Wu","year":"2021","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.isci.2026.116334_bib8","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s11136-016-1443-y","article-title":"Condition-specific or generic preference-based measures in oncology? A comparison of the EORTC-8D and the EQ-5D-3L","volume":"26","author":"Lorgelly","year":"2017","journal-title":"Qual. Life Res."},{"key":"10.1016\/j.isci.2026.116334_bib9","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s10198-017-0902-x","article-title":"What is the evidence for the performance of generic preference-based measures? A systematic overview of reviews","volume":"19","author":"Finch","year":"2018","journal-title":"Eur. J. Health Econ."},{"key":"10.1016\/j.isci.2026.116334_bib10","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.jval.2021.05.022","article-title":"A Comparison of Generic and Condition-Specific Preference-Based Measures Using Data From Nivolumab Trials: EQ-5D-3L, Mapping to the EQ-5D-5L, and European Organisation for Research and Treatment of Cancer Quality of Life Utility Measure-Core 10 Dimensions","volume":"24","author":"Shaw","year":"2021","journal-title":"Value Health"},{"key":"10.1016\/j.isci.2026.116334_bib11","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s11136-015-1217-y","article-title":"QLU-C10D: a health state classification system for a multi-attribute utility measure based on the EORTC QLQ-C30","volume":"25","author":"King","year":"2016","journal-title":"Qual. Life Res."},{"key":"10.1016\/j.isci.2026.116334_bib12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jclinepi.2021.03.015","article-title":"The EORTC QLU-C10D was more efficient in detecting clinical known group differences in myelodysplastic syndromes than the EQ-5D-3L","volume":"137","author":"Gamper","year":"2021","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.isci.2026.116334_bib13","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/s12955-021-01867-w","article-title":"Responsiveness and convergent validity of QLU-C10D and EQ-5D-3L in assessing short-term quality of life following esophagectomy","volume":"19","author":"Bulamu","year":"2021","journal-title":"Health Qual. Life Outcomes"},{"key":"10.1016\/j.isci.2026.116334_bib14","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.jval.2012.08.2201","article-title":"Comparison of generic, condition-specific, and mapped health state utility values for multiple myeloma cancer","volume":"15","author":"Rowen","year":"2012","journal-title":"Value Health"},{"key":"10.1016\/j.isci.2026.116334_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta18090","article-title":"Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey","volume":"18","author":"Longworth","year":"2014","journal-title":"Health Technol. Assess."},{"key":"10.1016\/j.isci.2026.116334_bib16","article-title":"Cultural beliefs, utility values, and health technology assessment","volume":"16","author":"Mahlich","year":"2018","journal-title":"Resour Alloc."},{"key":"10.1016\/j.isci.2026.116334_bib17","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s40273-017-0582-5","article-title":"Australian Utility Weights for the EORTC QLU-C10D, a Multi-Attribute Utility Instrument Derived from the Cancer-Specific Quality of Life Questionnaire, EORTC QLQ-C30","volume":"36","author":"King","year":"2018","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.isci.2026.116334_bib18","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1007\/s11136-019-02283-w","article-title":"German value sets for the EORTC QLU-C10D, a cancer-specific utility instrument based on the EORTC QLQ-C30","volume":"28","author":"Kemmler","year":"2019","journal-title":"Qual. Life Res."},{"key":"10.1016\/j.isci.2026.116334_bib19","article-title":"The EORTC QLU-C10D: The Canadian Valuation Study and Algorithm to Derive Cancer-Specific Utilities From the EORTC QLQ-C30","volume":"4","author":"McTaggart-Cowan","year":"2019","journal-title":"MDM Policy Pract."},{"key":"10.1016\/j.isci.2026.116334_bib20","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1002\/hec.3950","article-title":"U.K. utility weights for the EORTC QLU-C10D","volume":"28","author":"Norman","year":"2019","journal-title":"Health Econ."},{"key":"10.1016\/j.isci.2026.116334_bib21","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1007\/s11136-020-02536-z","article-title":"EORTC QLU-C10D value sets for Austria, Italy, and Poland","volume":"29","author":"Gamper","year":"2020","journal-title":"Qual. Life Res."},{"key":"10.1016\/j.isci.2026.116334_bib22","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s40273-021-01058-x","article-title":"Estimation of an EORTC QLU-C10 Value Set for Spain Using a Discrete Choice Experiment","volume":"39","author":"Finch","year":"2021","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.isci.2026.116334_bib23","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1007\/s11136-021-02767-8","article-title":"Dutch utility weights for the EORTC cancer-specific utility instrument: the Dutch EORTC QLU-C10D","volume":"30","author":"Jansen","year":"2021","journal-title":"Qual. Life Res."},{"key":"10.1016\/j.isci.2026.116334_bib24","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s40258-020-00598-1","article-title":"French Value-Set of the QLU-C10D, a Cancer-Specific Utility Measure Derived from the QLQ-C30","volume":"19","author":"Nerich","year":"2021","journal-title":"Appl. Health Econ. Health Policy"},{"key":"10.1016\/j.isci.2026.116334_bib25","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1177\/0272989X211003569","article-title":"United States Utility Algorithm for the EORTC QLU-C10D, a Multiattribute Utility Instrument Based on a Cancer-Specific Quality-of-Life Instrument","volume":"41","author":"Revicki","year":"2021","journal-title":"Med. Decis. Mak."},{"key":"10.1016\/j.isci.2026.116334_bib26","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s11136-023-03569-w","article-title":"Danish value sets for the EORTC QLU-C10D utility instrument","volume":"33","author":"Lehmann","year":"2024","journal-title":"Qual. Life Res."},{"key":"10.1016\/j.isci.2026.116334_bib27","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1007\/s11136-024-03655-7","article-title":"Japanese value set for the EORTC QLU-C10D: A multi-attribute utility instrument based on the EORTC QLQ-C30 cancer-specific quality-of-life questionnaire","volume":"33","author":"Shiroiwa","year":"2024","journal-title":"Qual. Life Res."},{"key":"10.1016\/j.isci.2026.116334_bib28","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1007\/s11136-024-03776-z","article-title":"Chinese utility weights for the EORTC cancer-specific utility instrument QLU-C10D","volume":"33","author":"Cao","year":"2024","journal-title":"Qual. Life Res."},{"key":"10.1016\/j.isci.2026.116334_bib29","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s11136-024-03824-8","article-title":"Norwegian and Swedish value sets for the EORTC QLU-C10D utility instrument","volume":"34","author":"Rohde","year":"2024","journal-title":"Qual. Life Res."},{"key":"10.1016\/j.isci.2026.116334_bib30","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s40271-016-0190-z","article-title":"EQ-5D Health Utility Scores: Data from a Comprehensive Canadian Cancer Centre","volume":"10","author":"Naik","year":"2017","journal-title":"Patient"},{"key":"10.1016\/j.isci.2026.116334_bib31","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.pharp.2026.01.002","article-title":"Direct oral anticoagulants in cancer-associated thrombosis: A systematic review of cost-effectiveness studies","volume":"1","author":"Elmeniar","year":"2025","journal-title":"Pharmacoeconomics and Policy"},{"key":"10.1016\/j.isci.2026.116334_bib32","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.pharp.2026.02.001","article-title":"Cost-effectiveness analysis of toripalimab plus bevacizumab versus sorafenib as first-line treatment for advanced hepatocellular carcinoma in China","volume":"2","author":"Jia","year":"2026","journal-title":"Pharmacoeconomics and Policy"},{"key":"10.1016\/j.isci.2026.116334_bib33","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12955-025-02332-8","article-title":"Health utility scores of six common cancers in China measured by SF-6Dv2","volume":"23","author":"Tao","year":"2025","journal-title":"Health Qual. Life Outcomes"},{"key":"10.1016\/j.isci.2026.116334_bib34","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.3892\/ol.2015.2944","article-title":"Depression in cancer patients: Pathogenesis, implications and treatment (Review)","volume":"9","author":"Smith","year":"2015","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.isci.2026.116334_bib35","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jad.2012.03.025","article-title":"Anxiety and depression after cancer diagnosis: prevalence rates by cancer type, gender, and age","volume":"141","author":"Linden","year":"2012","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.isci.2026.116334_bib36","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1007\/s10198-024-01670-6","article-title":"The EORTC QLU-C10D is a valid cancer-specific preference-based measure for cost-utility and health technology assessment in the Netherlands","volume":"25","author":"Pilz","year":"2024","journal-title":"Eur. J. Health Econ."},{"key":"10.1016\/j.isci.2026.116334_bib37","article-title":"Health-related quality of life and health utility score of patients with gastric cancer: A multi-centre cross-sectional survey in China","volume":"29","author":"Xia","year":"2020","journal-title":"Eur. J. Cancer Care"},{"key":"10.1016\/j.isci.2026.116334_bib38","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00148-016-0611-2","article-title":"Happiness, stress, and age: how the U curve varies across people and places","volume":"30","author":"Graham","year":"2016","journal-title":"J. Popul. Econ."},{"key":"10.1016\/j.isci.2026.116334_bib39","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jpsychores.2017.09.016","article-title":"Psychological stress declines rapidly from age 50 in the United States: Yet another well-being paradox","volume":"103","author":"Stone","year":"2017","journal-title":"J. Psychosom. Res."},{"key":"10.1016\/j.isci.2026.116334_bib40","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s10926-018-9789-3","article-title":"Work Transitions in Breast Cancer Survivors and Effects on Quality of Life","volume":"29","author":"Hamood","year":"2019","journal-title":"J. Occup. Rehabil."},{"key":"10.1016\/j.isci.2026.116334_bib41","doi-asserted-by":"crossref","DOI":"10.4178\/epih.e2023092","article-title":"Cancer risk based on alcohol consumption levels: a comprehensive systematic review and meta-analysis","volume":"45","author":"Jun","year":"2023","journal-title":"Epidemiol. Health"},{"key":"10.1016\/j.isci.2026.116334_bib42","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.20382","article-title":"Association of the Frequency and Quantity of Alcohol Consumption With Gastrointestinal Cancer","volume":"4","author":"Yoo","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.isci.2026.116334_bib43","first-page":"43","article-title":"American Cancer Society\/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline","volume":"66","author":"Runowicz","year":"2016","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.isci.2026.116334_bib44","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.athoracsur.2022.07.029","article-title":"Long-Term Quality of Life After Esophagectomy for Esophageal Cancer","volume":"115","author":"Katz","year":"2023","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.isci.2026.116334_bib45","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13561-024-00560-0","article-title":"A comparison of measurement properties between EORTC QLU-C10D and FACT-8D in patients with hematological malignances","volume":"14","author":"Cao","year":"2024","journal-title":"Health Econ. Rev."},{"key":"10.1016\/j.isci.2026.116334_bib46","article-title":"Quality of life utility-Core 10 dimensions (QLU-C10D) scores based on cancer patients' health preferences are more sensitive than those based on general public's health preferences","author":"Cao","year":"2025","journal-title":"Eur. J. Health Econ."},{"key":"10.1016\/j.isci.2026.116334_bib47","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11136-026-04183-2","article-title":"Cancer-specific or generic preference-based measures in oncology? A validity comparison across six commonly diagnosed cancers","volume":"35","author":"Cao","year":"2026","journal-title":"Qual. Life Res."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226017098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226017098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T01:20:20Z","timestamp":1788225620000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004226017098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":47,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2589004226017098"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2026.116334","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing the health utility values of patients with six common cancers in China using the QLU-C10D: A cross-sectional survey","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2026.116334","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116334"}}